Do people who take these drugs to lose weight need to keep taking them forever
Protein-and calcium-mediated GLP-1 secretion: a narrative review
In reality, how therapy is reduced or discontinued can significantly influence long-term outcomes especially the risk of rebound weight gain
Its the perfect duo to keep you glowing and confident, no matter whats on your schedule
Due to their cost, however, coverage of GLP-1s for obesity treatment in Medicaid, ACA Marketplace plans, and most large employer firms remains limited, and GLP-1 coverage in Medicare for treatment of obesity is prohibited under current law
Our study extends beyond the work of Xie and colleagues by examining an even broader range of clinical outcomes (up to 1,026 phenotypes) while leveraging electronic health record (EHR) data from the All of Us Research program (AOU), 65 a nationally recruited EHR-linked biobank specifically designed to oversample groups historically underrepresented in biomedical research
.jpg)
.png)
